---
title: 'High-dose chemotherapy and autologous haematopoietic stem-cell transplantation
  in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a
  single-arm, phase 2 trial'
date: '2024-02-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38301670/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240202170634&v=2.18.0
source: heidelberg[Affiliation]
description: 'BACKGROUND: Available treatments for older patients with primary diffuse
  large B-cell CNS lymphoma (PCNSL) offer progression-free survival of up to 16 months.
  We aimed to investigate an intensified treatment of high-dose chemotherapy and autologous
  haematopoietic stem-cell transplantation (HSCT) in older patients with ...'
disable_comments: true
---
BACKGROUND: Available treatments for older patients with primary diffuse large B-cell CNS lymphoma (PCNSL) offer progression-free survival of up to 16 months. We aimed to investigate an intensified treatment of high-dose chemotherapy and autologous haematopoietic stem-cell transplantation (HSCT) in older patients with ...